Experience. Commitment. Results.
Mr. Cooper Group Inc. (NASDAQ: COOP), relating to the proposed merger with Rocket Companies. Under the terms of the agreement, Mr. Cooper shareholders will receive a fixed exchange ratio of 11.0 Rocket shares for each share of Mr. Cooper common stock. Mr. Cooper shareholders will own approximately 25% of the combined company.
Dun & Bradstreet Holdings, Inc. (NYSE: DNB), relating to the proposed merger with Clearlake Capital Group, L.P. Under the terms of the agreement, Dun & Bradstreet shareholders will receive $9.15 in cash for each share of common stock they own.
LENSAR, Inc. (NASDAQ: LNSR), relating to the proposed merger with Alcon. Under the terms of the agreement, LENSAR shareholders will receive $14.00 per share, with an additional non-tradeable contingent value right offering up to $2.75 per share in cash conditioned on the achievement of certain milestones.
The AZEK Company Inc. (NYSE: AZEK), relating to the proposed merger with James Hardie Industries plc. Under the terms of the agreement, AZEK shareholders will receive $26.45 in cash and 1.0340 ordinary shares of James Hardie per share of AZEK common stock owned.
Beacon Roofing Supply, Inc. (NASDAQ: BECN), relating to the proposed merger with QXO, Inc. Under the terms of the agreement, Beacon shareholders will receive $124.35 per share in cash.
OptiNose, Inc. (NASDAQ: OPTN), relating to the proposed merger with Paratek Pharmaceuticals. Under the terms of the agreement, OptiNose shareholders will have the right to receive $9.00 in cash per share of stock owned, and one contractual contingent value right.
Radius Recycling, Inc. (NASDAQ: RDUS), relating to the proposed merger with Toyota Tsusho America, Inc. Under the terms of the agreement, Toyota Tsusho will acquire all shares of Radius, with Radius shareholders receiving $30.00 per share in cash.
Endo, Inc. (OTC: NDOI), relating to the proposed merger with Mallinckrodt plc. Under the terms of the agreement, Endo shareholders will own 49.9% of the combined company on a pro forma basis.
2seventy bio, Inc. (NASDAQ: TSVT), relating to the proposed merger with Bristol Myers Squibb. Under the terms of the agreement, Bristol Myers Squibb will acquire 2seventy bio, with 2seventy shareholders receiving $5.00 per share in cash.
Avalon GloboCare Corp. (NASDAQ: ALBT), relating to the proposed merger with YOOV Group Holding Limited. Under the terms of the agreement, Avalon equity holders are expected to own between approximately 2.5% to 2.2% of the common stock of the combined company.